nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PLA2G4A—Epirubicin—thyroid cancer	0.525	0.697	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0616	0.0818	CbGbCtD
Fluticasone Propionate—CYP3A7—Sorafenib—thyroid cancer	0.0616	0.0818	CbGbCtD
Fluticasone Propionate—CYP3A5—Sorafenib—thyroid cancer	0.0462	0.0614	CbGbCtD
Fluticasone Propionate—CYP3A4—Vandetanib—thyroid cancer	0.0299	0.0397	CbGbCtD
Fluticasone Propionate—CYP3A4—Sorafenib—thyroid cancer	0.018	0.0239	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—thyroid cancer	0.0109	0.0145	CbGbCtD
Fluticasone Propionate—NR3C2—Preimplantation Embryo—TCF7L1—thyroid cancer	0.00284	0.036	CbGpPWpGaD
Fluticasone Propionate—PGR—Nuclear Receptors—THRB—thyroid cancer	0.00263	0.0333	CbGpPWpGaD
Fluticasone Propionate—PGR—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.00208	0.0263	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00203	0.0257	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of Androgen receptor activity—TRIM24—thyroid cancer	0.00181	0.0229	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Ca-dependent events—PRKAR1A—thyroid cancer	0.00172	0.0218	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Nuclear Receptors—THRB—thyroid cancer	0.00152	0.0192	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CITED1—thyroid cancer	0.00151	0.0192	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00145	0.0183	CbGpPWpGaD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NKX2-1—thyroid cancer	0.00142	0.0179	CbGpPWpGaD
Fluticasone Propionate—Bronchospasm—Vandetanib—thyroid cancer	0.00139	0.00869	CcSEcCtD
Fluticasone Propionate—Bronchitis—Vandetanib—thyroid cancer	0.00136	0.00849	CcSEcCtD
Fluticasone Propionate—Leukoderma—Epirubicin—thyroid cancer	0.00132	0.00825	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Vandetanib—thyroid cancer	0.00131	0.00821	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Vandetanib—thyroid cancer	0.00128	0.00797	CcSEcCtD
Fluticasone Propionate—Pneumonia—Vandetanib—thyroid cancer	0.00127	0.00792	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PLC beta mediated events—PRKAR1A—thyroid cancer	0.00127	0.0161	CbGpPWpGaD
Fluticasone Propionate—Infestation NOS—Vandetanib—thyroid cancer	0.00126	0.00787	CcSEcCtD
Fluticasone Propionate—Infestation—Vandetanib—thyroid cancer	0.00126	0.00787	CcSEcCtD
Fluticasone Propionate—PLA2G4A—G-protein mediated events—PRKAR1A—thyroid cancer	0.00125	0.0158	CbGpPWpGaD
Fluticasone Propionate—Eczema—Sorafenib—thyroid cancer	0.00123	0.00767	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Vandetanib—thyroid cancer	0.00123	0.00765	CcSEcCtD
Fluticasone Propionate—Leukoderma—Doxorubicin—thyroid cancer	0.00122	0.00764	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptor transcription pathway—THRB—thyroid cancer	0.0012	0.0152	CbGpPWpGaD
Fluticasone Propionate—Epistaxis—Vandetanib—thyroid cancer	0.00119	0.00743	CcSEcCtD
Fluticasone Propionate—Sinusitis—Vandetanib—thyroid cancer	0.00118	0.00739	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptors—RXRA—thyroid cancer	0.00112	0.0141	CbGpPWpGaD
Fluticasone Propionate—Eye disorder—Vandetanib—thyroid cancer	0.00106	0.00661	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Vandetanib—thyroid cancer	0.00105	0.00656	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Vandetanib—thyroid cancer	0.00102	0.00637	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Vandetanib—thyroid cancer	0.00101	0.00631	CcSEcCtD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—NKX2-1—thyroid cancer	0.000999	0.0127	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—RXRA—thyroid cancer	0.000999	0.0127	CbGpPWpGaD
Fluticasone Propionate—Mental disorder—Vandetanib—thyroid cancer	0.000992	0.00619	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Sorafenib—thyroid cancer	0.000987	0.00616	CcSEcCtD
Fluticasone Propionate—Malnutrition—Vandetanib—thyroid cancer	0.000986	0.00615	CcSEcCtD
Fluticasone Propionate—Lacrimation—Epirubicin—thyroid cancer	0.000956	0.00597	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Vandetanib—thyroid cancer	0.000948	0.00592	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.000945	0.012	CbGpPWpGaD
Fluticasone Propionate—Vision blurred—Vandetanib—thyroid cancer	0.000929	0.0058	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—LGALS3—thyroid cancer	0.000924	0.0117	CbGpPWpGaD
Fluticasone Propionate—Tremor—Vandetanib—thyroid cancer	0.000923	0.00576	CcSEcCtD
Fluticasone Propionate—Abdominal discomfort—Sorafenib—thyroid cancer	0.000915	0.00571	CcSEcCtD
Fluticasone Propionate—NR3C2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000914	0.0116	CbGpPWpGaD
Fluticasone Propionate—Folliculitis—Epirubicin—thyroid cancer	0.000894	0.00558	CcSEcCtD
Fluticasone Propionate—Psoriasis—Epirubicin—thyroid cancer	0.000894	0.00558	CcSEcCtD
Fluticasone Propionate—PLA2G4A—saliva-secreting gland—thyroid cancer	0.000887	0.109	CbGeAlD
Fluticasone Propionate—Oral candidiasis—Epirubicin—thyroid cancer	0.000885	0.00552	CcSEcCtD
Fluticasone Propionate—Lacrimation—Doxorubicin—thyroid cancer	0.000884	0.00552	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000882	0.0112	CbGpPWpGaD
Fluticasone Propionate—Cough—Vandetanib—thyroid cancer	0.00086	0.00537	CcSEcCtD
Fluticasone Propionate—Pneumonia—Sorafenib—thyroid cancer	0.000856	0.00534	CcSEcCtD
Fluticasone Propionate—Hypertension—Vandetanib—thyroid cancer	0.000851	0.00531	CcSEcCtD
Fluticasone Propionate—Infestation—Sorafenib—thyroid cancer	0.000851	0.00531	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Sorafenib—thyroid cancer	0.000851	0.00531	CcSEcCtD
Fluticasone Propionate—Arthralgia—Vandetanib—thyroid cancer	0.000839	0.00524	CcSEcCtD
Fluticasone Propionate—Chest pain—Vandetanib—thyroid cancer	0.000839	0.00524	CcSEcCtD
Fluticasone Propionate—Anxiety—Vandetanib—thyroid cancer	0.000836	0.00522	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.000833	0.0052	CcSEcCtD
Fluticasone Propionate—Folliculitis—Doxorubicin—thyroid cancer	0.000827	0.00517	CcSEcCtD
Fluticasone Propionate—Psoriasis—Doxorubicin—thyroid cancer	0.000827	0.00517	CcSEcCtD
Fluticasone Propionate—Dry mouth—Vandetanib—thyroid cancer	0.000821	0.00512	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Doxorubicin—thyroid cancer	0.000819	0.00511	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000814	0.0103	CbGpPWpGaD
Fluticasone Propionate—Oedema—Vandetanib—thyroid cancer	0.000804	0.00502	CcSEcCtD
Fluticasone Propionate—Epistaxis—Sorafenib—thyroid cancer	0.000802	0.00501	CcSEcCtD
Fluticasone Propionate—Infection—Vandetanib—thyroid cancer	0.000799	0.00499	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Vandetanib—thyroid cancer	0.000789	0.00492	CcSEcCtD
Fluticasone Propionate—Skin disorder—Vandetanib—thyroid cancer	0.000781	0.00488	CcSEcCtD
Fluticasone Propionate—Blister—Epirubicin—thyroid cancer	0.00078	0.00487	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Opioid Signalling—PRKAR1A—thyroid cancer	0.000778	0.00986	CbGpPWpGaD
Fluticasone Propionate—Dermatitis atopic—Epirubicin—thyroid cancer	0.000759	0.00474	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Sorafenib—thyroid cancer	0.00075	0.00469	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Epirubicin—thyroid cancer	0.000734	0.00458	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000733	0.00458	CcSEcCtD
Fluticasone Propionate—Blister—Doxorubicin—thyroid cancer	0.000721	0.0045	CcSEcCtD
Fluticasone Propionate—NR3C2—saliva-secreting gland—thyroid cancer	0.000721	0.089	CbGeAlD
Fluticasone Propionate—Dyspnoea—Vandetanib—thyroid cancer	0.000717	0.00448	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Sorafenib—thyroid cancer	0.000709	0.00443	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptors—PPARG—thyroid cancer	0.000705	0.00893	CbGpPWpGaD
Fluticasone Propionate—Dermatitis atopic—Doxorubicin—thyroid cancer	0.000703	0.00439	CcSEcCtD
Fluticasone Propionate—Ageusia—Epirubicin—thyroid cancer	0.000694	0.00433	CcSEcCtD
Fluticasone Propionate—Stinging—Epirubicin—thyroid cancer	0.000694	0.00433	CcSEcCtD
Fluticasone Propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—thyroid cancer	0.000691	0.00875	CbGpPWpGaD
Fluticasone Propionate—Immune system disorder—Sorafenib—thyroid cancer	0.00069	0.00431	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Sorafenib—thyroid cancer	0.000688	0.0043	CcSEcCtD
Fluticasone Propionate—Pain—Vandetanib—thyroid cancer	0.000688	0.00429	CcSEcCtD
Fluticasone Propionate—PLA2G4A—trachea—thyroid cancer	0.000684	0.0844	CbGeAlD
Fluticasone Propionate—Dysphonia—Epirubicin—thyroid cancer	0.000683	0.00427	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Sorafenib—thyroid cancer	0.000682	0.00426	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Doxorubicin—thyroid cancer	0.000679	0.00424	CcSEcCtD
Fluticasone Propionate—Mental disorder—Sorafenib—thyroid cancer	0.000669	0.00418	CcSEcCtD
Fluticasone Propionate—Malnutrition—Sorafenib—thyroid cancer	0.000665	0.00415	CcSEcCtD
Fluticasone Propionate—Erythema—Sorafenib—thyroid cancer	0.000665	0.00415	CcSEcCtD
Fluticasone Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—RXRA—thyroid cancer	0.000659	0.00835	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.000658	0.00411	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptors—RXRA—thyroid cancer	0.000645	0.00817	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metapathway biotransformation—CHST14—thyroid cancer	0.000643	0.00815	CbGpPWpGaD
Fluticasone Propionate—Stinging—Doxorubicin—thyroid cancer	0.000642	0.00401	CcSEcCtD
Fluticasone Propionate—Ageusia—Doxorubicin—thyroid cancer	0.000642	0.00401	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Sorafenib—thyroid cancer	0.000639	0.00399	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Vandetanib—thyroid cancer	0.000636	0.00397	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Vandetanib—thyroid cancer	0.000636	0.00397	CcSEcCtD
Fluticasone Propionate—Dysphonia—Doxorubicin—thyroid cancer	0.000632	0.00395	CcSEcCtD
Fluticasone Propionate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—thyroid cancer	0.000631	0.00799	CbGpPWpGaD
Fluticasone Propionate—Viral infection—Epirubicin—thyroid cancer	0.000622	0.00388	CcSEcCtD
Fluticasone Propionate—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.000621	0.00787	CbGpPWpGaD
Fluticasone Propionate—Lacrimation increased—Epirubicin—thyroid cancer	0.00061	0.00381	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Epirubicin—thyroid cancer	0.00061	0.00381	CcSEcCtD
Fluticasone Propionate—Angioedema—Sorafenib—thyroid cancer	0.000607	0.00379	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—THRB—thyroid cancer	0.000589	0.00746	CbGpPWpGaD
Fluticasone Propionate—Cough—Sorafenib—thyroid cancer	0.00058	0.00362	CcSEcCtD
Fluticasone Propionate—Viral infection—Doxorubicin—thyroid cancer	0.000576	0.00359	CcSEcCtD
Fluticasone Propionate—Hypertension—Sorafenib—thyroid cancer	0.000574	0.00358	CcSEcCtD
Fluticasone Propionate—Pruritus—Vandetanib—thyroid cancer	0.000569	0.00355	CcSEcCtD
Fluticasone Propionate—Arthralgia—Sorafenib—thyroid cancer	0.000566	0.00353	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Doxorubicin—thyroid cancer	0.000564	0.00352	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Doxorubicin—thyroid cancer	0.000564	0.00352	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000562	0.00351	CcSEcCtD
Fluticasone Propionate—PGR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000557	0.00705	CbGpPWpGaD
Fluticasone Propionate—NR3C2—trachea—thyroid cancer	0.000557	0.0686	CbGeAlD
Fluticasone Propionate—Dermatitis contact—Epirubicin—thyroid cancer	0.000555	0.00347	CcSEcCtD
Fluticasone Propionate—Dry mouth—Sorafenib—thyroid cancer	0.000554	0.00346	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vandetanib—thyroid cancer	0.00055	0.00344	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—thyroid cancer	0.000547	0.00693	CbGpPWpGaD
Fluticasone Propionate—Influenza like illness—Epirubicin—thyroid cancer	0.000546	0.00341	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Sorafenib—thyroid cancer	0.000543	0.00339	CcSEcCtD
Fluticasone Propionate—PLA2G4A—thyroid gland—thyroid cancer	0.000541	0.0668	CbGeAlD
Fluticasone Propionate—Infection—Sorafenib—thyroid cancer	0.000539	0.00337	CcSEcCtD
Fluticasone Propionate—Candida infection—Epirubicin—thyroid cancer	0.000537	0.00335	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Sorafenib—thyroid cancer	0.000532	0.00332	CcSEcCtD
Fluticasone Propionate—Dizziness—Vandetanib—thyroid cancer	0.000532	0.00332	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.000528	0.00669	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000527	0.00668	CbGpPWpGaD
Fluticasone Propionate—Skin disorder—Sorafenib—thyroid cancer	0.000527	0.00329	CcSEcCtD
Fluticasone Propionate—Dermatitis contact—Doxorubicin—thyroid cancer	0.000514	0.00321	CcSEcCtD
Fluticasone Propionate—Vomiting—Vandetanib—thyroid cancer	0.000511	0.00319	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.00051	0.00646	CbGpPWpGaD
Fluticasone Propionate—Rash—Vandetanib—thyroid cancer	0.000507	0.00317	CcSEcCtD
Fluticasone Propionate—Dermatitis—Vandetanib—thyroid cancer	0.000507	0.00316	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Doxorubicin—thyroid cancer	0.000505	0.00315	CcSEcCtD
Fluticasone Propionate—Headache—Vandetanib—thyroid cancer	0.000504	0.00315	CcSEcCtD
Fluticasone Propionate—Candida infection—Doxorubicin—thyroid cancer	0.000496	0.0031	CcSEcCtD
Fluticasone Propionate—NR3C1—neck—thyroid cancer	0.000496	0.0612	CbGeAlD
Fluticasone Propionate—PGR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000496	0.00628	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.000494	0.00626	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000494	0.00309	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.000491	0.00621	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Sorafenib—thyroid cancer	0.000484	0.00302	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	0.000484	0.00613	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.00048	0.00608	CbGpPWpGaD
Fluticasone Propionate—SERPINA6—head—thyroid cancer	0.000478	0.059	CbGeAlD
Fluticasone Propionate—Nausea—Vandetanib—thyroid cancer	0.000478	0.00298	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Epirubicin—thyroid cancer	0.000469	0.00293	CcSEcCtD
Fluticasone Propionate—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	0.000465	0.00589	CbGpPWpGaD
Fluticasone Propionate—Pain—Sorafenib—thyroid cancer	0.000464	0.0029	CcSEcCtD
Fluticasone Propionate—Eczema—Epirubicin—thyroid cancer	0.000454	0.00283	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000444	0.00277	CcSEcCtD
Fluticasone Propionate—CYP3A7—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000441	0.00559	CbGpPWpGaD
Fluticasone Propionate—NR3C2—thyroid gland—thyroid cancer	0.00044	0.0543	CbGeAlD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—HIF1A—thyroid cancer	0.000435	0.00551	CbGpPWpGaD
Fluticasone Propionate—Diabetes mellitus—Doxorubicin—thyroid cancer	0.000434	0.00271	CcSEcCtD
Fluticasone Propionate—Urticaria—Sorafenib—thyroid cancer	0.000431	0.00269	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Sorafenib—thyroid cancer	0.000429	0.00268	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Sorafenib—thyroid cancer	0.000429	0.00268	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Epirubicin—thyroid cancer	0.000427	0.00267	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.000426	0.0054	CbGpPWpGaD
Fluticasone Propionate—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000422	0.00263	CcSEcCtD
Fluticasone Propionate—Eczema—Doxorubicin—thyroid cancer	0.00042	0.00262	CcSEcCtD
Fluticasone Propionate—PGR—thyroid gland—thyroid cancer	0.000409	0.0505	CbGeAlD
Fluticasone Propionate—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.000407	0.00516	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Sorafenib—thyroid cancer	0.0004	0.0025	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—CDK1—thyroid cancer	0.000397	0.00502	CbGpPWpGaD
Fluticasone Propionate—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000395	0.00247	CcSEcCtD
Fluticasone Propionate—Face oedema—Epirubicin—thyroid cancer	0.000394	0.00246	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—TRIM33—thyroid cancer	0.000392	0.00497	CbGpPWpGaD
Fluticasone Propionate—NR3C2—head—thyroid cancer	0.000391	0.0482	CbGeAlD
Fluticasone Propionate—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00039	0.00244	CcSEcCtD
Fluticasone Propionate—NR3C1—saliva-secreting gland—thyroid cancer	0.000387	0.0477	CbGeAlD
Fluticasone Propionate—Pruritus—Sorafenib—thyroid cancer	0.000384	0.0024	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—MEN1—thyroid cancer	0.000374	0.00474	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000372	0.00471	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Sorafenib—thyroid cancer	0.000371	0.00232	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Epirubicin—thyroid cancer	0.000365	0.00228	CcSEcCtD
Fluticasone Propionate—Face oedema—Doxorubicin—thyroid cancer	0.000364	0.00228	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000364	0.00461	CbGpPWpGaD
Fluticasone Propionate—PGR—head—thyroid cancer	0.000363	0.0448	CbGeAlD
Fluticasone Propionate—Dizziness—Sorafenib—thyroid cancer	0.000359	0.00224	CcSEcCtD
Fluticasone Propionate—PGR—Generic Transcription Pathway—THRB—thyroid cancer	0.000359	0.00454	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000357	0.00453	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.000356	0.00451	CbGpPWpGaD
Fluticasone Propionate—Abdominal distension—Epirubicin—thyroid cancer	0.000355	0.00222	CcSEcCtD
Fluticasone Propionate—Asthma—Epirubicin—thyroid cancer	0.000353	0.0022	CcSEcCtD
Fluticasone Propionate—Vomiting—Sorafenib—thyroid cancer	0.000345	0.00215	CcSEcCtD
Fluticasone Propionate—Rash—Sorafenib—thyroid cancer	0.000342	0.00214	CcSEcCtD
Fluticasone Propionate—Dermatitis—Sorafenib—thyroid cancer	0.000342	0.00213	CcSEcCtD
Fluticasone Propionate—Headache—Sorafenib—thyroid cancer	0.00034	0.00212	CcSEcCtD
Fluticasone Propionate—Bronchitis—Epirubicin—thyroid cancer	0.000339	0.00212	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000338	0.00211	CcSEcCtD
Fluticasone Propionate—PLA2G4A—lymph node—thyroid cancer	0.000336	0.0415	CbGeAlD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.00033	0.00418	CbGpPWpGaD
Fluticasone Propionate—Abdominal distension—Doxorubicin—thyroid cancer	0.000328	0.00205	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000328	0.00205	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—thyroid cancer	0.000326	0.00204	CcSEcCtD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000326	0.00413	CbGpPWpGaD
Fluticasone Propionate—Nausea—Sorafenib—thyroid cancer	0.000322	0.00201	CcSEcCtD
Fluticasone Propionate—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000322	0.00408	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000319	0.00404	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—NRG1—thyroid cancer	0.000318	0.00403	CbGpPWpGaD
Fluticasone Propionate—Hyperglycaemia—Epirubicin—thyroid cancer	0.000318	0.00199	CcSEcCtD
Fluticasone Propionate—Pneumonia—Epirubicin—thyroid cancer	0.000316	0.00197	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Epirubicin—thyroid cancer	0.000314	0.00196	CcSEcCtD
Fluticasone Propionate—Infestation—Epirubicin—thyroid cancer	0.000314	0.00196	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—thyroid cancer	0.000314	0.00196	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Epirubicin—thyroid cancer	0.000306	0.00191	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000303	0.00189	CcSEcCtD
Fluticasone Propionate—NR3C1—trachea—thyroid cancer	0.000299	0.0368	CbGeAlD
Fluticasone Propionate—Epistaxis—Epirubicin—thyroid cancer	0.000297	0.00185	CcSEcCtD
Fluticasone Propionate—Sinusitis—Epirubicin—thyroid cancer	0.000295	0.00184	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000294	0.00184	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000294	0.00372	CbGpPWpGaD
Fluticasone Propionate—Pneumonia—Doxorubicin—thyroid cancer	0.000293	0.00183	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—thyroid cancer	0.000291	0.00182	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—thyroid cancer	0.000291	0.00182	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00029	0.00367	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000288	0.00365	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000287	0.00363	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—THRB—thyroid cancer	0.000283	0.00359	CbGpPWpGaD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—thyroid cancer	0.000283	0.00177	CcSEcCtD
Fluticasone Propionate—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—thyroid cancer	0.000282	0.00357	CbGpPWpGaD
Fluticasone Propionate—Hypoaesthesia—Epirubicin—thyroid cancer	0.000281	0.00175	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Epirubicin—thyroid cancer	0.00028	0.00175	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Epirubicin—thyroid cancer	0.000277	0.00173	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—thyroid cancer	0.000274	0.00171	CcSEcCtD
Fluticasone Propionate—NR3C2—lymph node—thyroid cancer	0.000273	0.0337	CbGeAlD
Fluticasone Propionate—Sinusitis—Doxorubicin—thyroid cancer	0.000273	0.0017	CcSEcCtD
Fluticasone Propionate—Eye disorder—Epirubicin—thyroid cancer	0.000264	0.00165	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Epirubicin—thyroid cancer	0.000262	0.00164	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00026	0.00162	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—thyroid cancer	0.000259	0.00162	CcSEcCtD
Fluticasone Propionate—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000258	0.00327	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000258	0.00326	CbGpPWpGaD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000257	0.0016	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Epirubicin—thyroid cancer	0.000255	0.00159	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Epirubicin—thyroid cancer	0.000254	0.00159	CcSEcCtD
Fluticasone Propionate—PGR—lymph node—thyroid cancer	0.000254	0.0314	CbGeAlD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—HRAS—thyroid cancer	0.000252	0.0032	CbGpPWpGaD
Fluticasone Propionate—Arrhythmia—Epirubicin—thyroid cancer	0.000252	0.00157	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000251	0.00317	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—RXRA—thyroid cancer	0.00025	0.00317	CbGpPWpGaD
Fluticasone Propionate—Mental disorder—Epirubicin—thyroid cancer	0.000247	0.00154	CcSEcCtD
Fluticasone Propionate—Erythema—Epirubicin—thyroid cancer	0.000246	0.00153	CcSEcCtD
Fluticasone Propionate—Malnutrition—Epirubicin—thyroid cancer	0.000246	0.00153	CcSEcCtD
Fluticasone Propionate—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000245	0.0031	CbGpPWpGaD
Fluticasone Propionate—Eye disorder—Doxorubicin—thyroid cancer	0.000244	0.00152	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—thyroid cancer	0.000242	0.00151	CcSEcCtD
Fluticasone Propionate—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.000241	0.00306	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—TRIM33—thyroid cancer	0.000239	0.00303	CbGpPWpGaD
Fluticasone Propionate—Muscle spasms—Epirubicin—thyroid cancer	0.000236	0.00147	CcSEcCtD
Fluticasone Propionate—NR3C1—thyroid gland—thyroid cancer	0.000236	0.0291	CbGeAlD
Fluticasone Propionate—Immune system disorder—Doxorubicin—thyroid cancer	0.000236	0.00147	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000235	0.00147	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—thyroid cancer	0.000233	0.00146	CcSEcCtD
Fluticasone Propionate—Vision blurred—Epirubicin—thyroid cancer	0.000232	0.00145	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—thyroid cancer	0.000229	0.00143	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000228	0.00142	CcSEcCtD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MEN1—thyroid cancer	0.000228	0.00288	CbGpPWpGaD
Fluticasone Propionate—Erythema—Doxorubicin—thyroid cancer	0.000227	0.00142	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—thyroid cancer	0.000227	0.00142	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CALCB—thyroid cancer	0.000227	0.00287	CbGpPWpGaD
Fluticasone Propionate—Agitation—Epirubicin—thyroid cancer	0.000226	0.00141	CcSEcCtD
Fluticasone Propionate—Malaise—Epirubicin—thyroid cancer	0.000222	0.00138	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—thyroid cancer	0.000219	0.00136	CcSEcCtD
Fluticasone Propionate—Palpitations—Epirubicin—thyroid cancer	0.000217	0.00136	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—BRAF—thyroid cancer	0.000216	0.00274	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000216	0.00274	CbGpPWpGaD
Fluticasone Propionate—Cough—Epirubicin—thyroid cancer	0.000214	0.00134	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—thyroid cancer	0.000214	0.00134	CcSEcCtD
Fluticasone Propionate—Hypertension—Epirubicin—thyroid cancer	0.000212	0.00132	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000211	0.00132	CcSEcCtD
Fluticasone Propionate—NR3C1—head—thyroid cancer	0.00021	0.0258	CbGeAlD
Fluticasone Propionate—Arthralgia—Epirubicin—thyroid cancer	0.000209	0.00131	CcSEcCtD
Fluticasone Propionate—Chest pain—Epirubicin—thyroid cancer	0.000209	0.00131	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—thyroid cancer	0.000209	0.0013	CcSEcCtD
Fluticasone Propionate—Anxiety—Epirubicin—thyroid cancer	0.000208	0.0013	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000208	0.0013	CcSEcCtD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.000207	0.00263	CbGpPWpGaD
Fluticasone Propionate—Discomfort—Epirubicin—thyroid cancer	0.000207	0.00129	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—thyroid cancer	0.000205	0.00128	CcSEcCtD
Fluticasone Propionate—Dry mouth—Epirubicin—thyroid cancer	0.000205	0.00128	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—thyroid cancer	0.000201	0.00125	CcSEcCtD
Fluticasone Propionate—Oedema—Epirubicin—thyroid cancer	0.000201	0.00125	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Epirubicin—thyroid cancer	0.000201	0.00125	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism—MINPP1—thyroid cancer	0.0002	0.00254	CbGpPWpGaD
Fluticasone Propionate—Infection—Epirubicin—thyroid cancer	0.000199	0.00124	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—thyroid cancer	0.000198	0.00124	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Epirubicin—thyroid cancer	0.000197	0.00123	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—thyroid cancer	0.000196	0.00123	CcSEcCtD
Fluticasone Propionate—Tachycardia—Epirubicin—thyroid cancer	0.000196	0.00122	CcSEcCtD
Fluticasone Propionate—Skin disorder—Epirubicin—thyroid cancer	0.000195	0.00122	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—thyroid cancer	0.000194	0.00121	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—thyroid cancer	0.000194	0.00121	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—thyroid cancer	0.000193	0.0012	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000192	0.0012	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—TPR—thyroid cancer	0.000191	0.00243	CbGpPWpGaD
Fluticasone Propionate—Discomfort—Doxorubicin—thyroid cancer	0.000191	0.00119	CcSEcCtD
Fluticasone Propionate—CYP3A7—Biological oxidations—RXRA—thyroid cancer	0.00019	0.00241	CbGpPWpGaD
Fluticasone Propionate—Dry mouth—Doxorubicin—thyroid cancer	0.000189	0.00118	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—thyroid cancer	0.000186	0.00116	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000186	0.00116	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—thyroid cancer	0.000184	0.00115	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000183	0.00114	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000182	0.00114	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—thyroid cancer	0.000181	0.00113	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—thyroid cancer	0.00018	0.00113	CcSEcCtD
Fluticasone Propionate—NR3C2—Gene Expression—MEN1—thyroid cancer	0.00018	0.00228	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PRKAR1A—thyroid cancer	0.00018	0.00228	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000179	0.00227	CbGpPWpGaD
Fluticasone Propionate—Dyspnoea—Epirubicin—thyroid cancer	0.000179	0.00112	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000178	0.00225	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—thyroid cancer	0.000177	0.00224	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—THRB—thyroid cancer	0.000173	0.00219	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—HRAS—thyroid cancer	0.000172	0.00218	CbGpPWpGaD
Fluticasone Propionate—Pain—Epirubicin—thyroid cancer	0.000171	0.00107	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000171	0.00217	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NDUFA13—thyroid cancer	0.00017	0.00216	CbGpPWpGaD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000169	0.00106	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—thyroid cancer	0.000165	0.00103	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Epirubicin—thyroid cancer	0.000165	0.00103	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000164	0.00102	CcSEcCtD
Fluticasone Propionate—PGR—Signaling Pathways—CALCB—thyroid cancer	0.000164	0.00207	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CHST14—thyroid cancer	0.00016	0.00203	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—PTEN—thyroid cancer	0.000159	0.00202	CbGpPWpGaD
Fluticasone Propionate—Urticaria—Epirubicin—thyroid cancer	0.000159	0.000995	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—thyroid cancer	0.000159	0.000991	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Epirubicin—thyroid cancer	0.000159	0.00099	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Epirubicin—thyroid cancer	0.000159	0.00099	CcSEcCtD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—PPARG—thyroid cancer	0.000158	0.002	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—thyroid cancer	0.000156	0.00197	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TRIM33—thyroid cancer	0.000155	0.00197	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000155	0.00196	CbGpPWpGaD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000153	0.000955	CcSEcCtD
Fluticasone Propionate—PGR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000152	0.00193	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—PTEN—thyroid cancer	0.000152	0.00193	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000152	0.00193	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—AKT1—thyroid cancer	0.000152	0.00192	CbGpPWpGaD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000152	0.000947	CcSEcCtD
Fluticasone Propionate—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000148	0.00188	CbGpPWpGaD
Fluticasone Propionate—Hypersensitivity—Epirubicin—thyroid cancer	0.000148	0.000922	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—thyroid cancer	0.000147	0.00092	CcSEcCtD
Fluticasone Propionate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000147	0.00187	CbGpPWpGaD
Fluticasone Propionate—NR3C1—lymph node—thyroid cancer	0.000147	0.0181	CbGeAlD
Fluticasone Propionate—Abdominal pain—Doxorubicin—thyroid cancer	0.000147	0.000916	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—thyroid cancer	0.000147	0.000916	CcSEcCtD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—AKT1—thyroid cancer	0.000146	0.00185	CbGpPWpGaD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000143	0.00181	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—NRAS—thyroid cancer	0.000142	0.0018	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Epirubicin—thyroid cancer	0.000142	0.000886	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Phospholipid metabolism—PTEN—thyroid cancer	0.000141	0.00178	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MINPP1—thyroid cancer	0.000139	0.00177	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.000138	0.00175	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Biological oxidations—RXRA—thyroid cancer	0.000137	0.00174	CbGpPWpGaD
Fluticasone Propionate—Diarrhoea—Epirubicin—thyroid cancer	0.000137	0.000857	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000137	0.000853	CcSEcCtD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—NRAS—thyroid cancer	0.000136	0.00172	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CALCB—thyroid cancer	0.000134	0.00169	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Epirubicin—thyroid cancer	0.000133	0.000828	CcSEcCtD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000132	0.00167	CbGpPWpGaD
Fluticasone Propionate—Pruritus—Doxorubicin—thyroid cancer	0.000131	0.00082	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Metabolism—HPGD—thyroid cancer	0.000129	0.00163	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Epirubicin—thyroid cancer	0.000127	0.000796	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—thyroid cancer	0.000127	0.000793	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TRIM33—thyroid cancer	0.000127	0.00161	CbGpPWpGaD
Fluticasone Propionate—Rash—Epirubicin—thyroid cancer	0.000126	0.000789	CcSEcCtD
Fluticasone Propionate—Dermatitis—Epirubicin—thyroid cancer	0.000126	0.000789	CcSEcCtD
Fluticasone Propionate—Headache—Epirubicin—thyroid cancer	0.000126	0.000784	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000124	0.00158	CbGpPWpGaD
Fluticasone Propionate—Dizziness—Doxorubicin—thyroid cancer	0.000123	0.000766	CcSEcCtD
Fluticasone Propionate—PGR—Signaling by ERBB4—KRAS—thyroid cancer	0.000122	0.00155	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—RXRA—thyroid cancer	0.00012	0.00153	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00012	0.00152	CbGpPWpGaD
Fluticasone Propionate—Nausea—Epirubicin—thyroid cancer	0.000119	0.000744	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Hemostasis—IFNA2—thyroid cancer	0.000119	0.00151	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NDUFA13—thyroid cancer	0.000119	0.0015	CbGpPWpGaD
Fluticasone Propionate—Vomiting—Doxorubicin—thyroid cancer	0.000118	0.000737	CcSEcCtD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000117	0.00148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—KRAS—thyroid cancer	0.000117	0.00148	CbGpPWpGaD
Fluticasone Propionate—Rash—Doxorubicin—thyroid cancer	0.000117	0.00073	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—thyroid cancer	0.000117	0.00073	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—TPR—thyroid cancer	0.000117	0.00148	CbGpPWpGaD
Fluticasone Propionate—Headache—Doxorubicin—thyroid cancer	0.000116	0.000726	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000112	0.00142	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CHST14—thyroid cancer	0.000112	0.00141	CbGpPWpGaD
Fluticasone Propionate—Nausea—Doxorubicin—thyroid cancer	0.00011	0.000688	CcSEcCtD
Fluticasone Propionate—PGR—Gene Expression—MEN1—thyroid cancer	0.00011	0.00139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000109	0.00137	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—TSHR—thyroid cancer	0.000105	0.00133	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000105	0.00133	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—HRAS—thyroid cancer	0.000104	0.00132	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TCF7L1—thyroid cancer	0.000104	0.00131	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000103	0.00131	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000103	0.00131	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MINPP1—thyroid cancer	0.000101	0.00128	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—THRB—thyroid cancer	9.98e-05	0.00126	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—HRAS—thyroid cancer	9.94e-05	0.00126	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—PPARG—thyroid cancer	9.62e-05	0.00122	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—AKT1—thyroid cancer	9.19e-05	0.00116	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HPGD—thyroid cancer	8.99e-05	0.00114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PTCH1—thyroid cancer	8.92e-05	0.00113	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	8.81e-05	0.00112	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	8.79e-05	0.00111	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	8.7e-05	0.0011	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NDUFA13—thyroid cancer	8.57e-05	0.00109	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TCF7L1—thyroid cancer	8.46e-05	0.00107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	8.33e-05	0.00106	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—SST—thyroid cancer	8.16e-05	0.00103	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CHST14—thyroid cancer	8.06e-05	0.00102	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CALCA—thyroid cancer	7.85e-05	0.000994	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PPARG—thyroid cancer	7.6e-05	0.000963	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TSHR—thyroid cancer	7.58e-05	0.000961	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PRKAR1A—thyroid cancer	7.46e-05	0.000945	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TPR—thyroid cancer	7.41e-05	0.000938	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	7.41e-05	0.000938	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—RXRA—thyroid cancer	7.34e-05	0.000929	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PRKAR1A—thyroid cancer	7.29e-05	0.000923	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MEN1—thyroid cancer	7.13e-05	0.000903	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CDK1—thyroid cancer	7.11e-05	0.0009	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—TPR—thyroid cancer	6.74e-05	0.000854	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.61e-05	0.000837	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HPGD—thyroid cancer	6.5e-05	0.000823	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTCH1—thyroid cancer	6.45e-05	0.000817	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.38e-05	0.000808	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MEN1—thyroid cancer	6.34e-05	0.000803	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	6.25e-05	0.000792	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TSHR—thyroid cancer	6.19e-05	0.000785	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PRKAR1A—thyroid cancer	6.09e-05	0.000772	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SST—thyroid cancer	5.9e-05	0.000747	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MEN1—thyroid cancer	5.82e-05	0.000738	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CALCA—thyroid cancer	5.68e-05	0.000719	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	5.57e-05	0.000705	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	5.56e-05	0.000704	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SLC5A5—thyroid cancer	5.55e-05	0.000702	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTCH1—thyroid cancer	5.27e-05	0.000667	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.2e-05	0.000658	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TPR—thyroid cancer	5.16e-05	0.000654	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDK1—thyroid cancer	5.14e-05	0.000651	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	5.08e-05	0.000643	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SST—thyroid cancer	4.82e-05	0.00061	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.69e-05	0.000594	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—RXRA—thyroid cancer	4.66e-05	0.00059	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CALCA—thyroid cancer	4.64e-05	0.000587	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—thyroid cancer	4.63e-05	0.000587	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.53e-05	0.000574	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NRAS—thyroid cancer	4.44e-05	0.000563	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RXRA—thyroid cancer	4.24e-05	0.000537	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDK1—thyroid cancer	4.2e-05	0.000532	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRG1—thyroid cancer	4.12e-05	0.000522	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.99e-05	0.000505	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC5A5—thyroid cancer	3.86e-05	0.00049	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—KRAS—thyroid cancer	3.82e-05	0.000484	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CHST14—thyroid cancer	3.75e-05	0.000475	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TPR—thyroid cancer	3.73e-05	0.000473	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TERT—thyroid cancer	3.7e-05	0.000469	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.67e-05	0.000465	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIF1A—thyroid cancer	3.54e-05	0.000449	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—thyroid cancer	3.4e-05	0.00043	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRG1—thyroid cancer	3.37e-05	0.000427	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—thyroid cancer	3.25e-05	0.000412	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—RXRA—thyroid cancer	3.25e-05	0.000411	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TERT—thyroid cancer	3.03e-05	0.000383	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HPGD—thyroid cancer	3.02e-05	0.000383	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—thyroid cancer	3.01e-05	0.000381	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—thyroid cancer	2.94e-05	0.000373	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BRAF—thyroid cancer	2.93e-05	0.000371	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—thyroid cancer	2.89e-05	0.000366	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—thyroid cancer	2.87e-05	0.000363	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.79e-05	0.000354	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—thyroid cancer	2.68e-05	0.000339	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—NRAS—thyroid cancer	2.55e-05	0.000323	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BRAF—thyroid cancer	2.4e-05	0.000303	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—RXRA—thyroid cancer	2.35e-05	0.000297	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—thyroid cancer	2.31e-05	0.000293	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—thyroid cancer	2.19e-05	0.000278	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—thyroid cancer	2.14e-05	0.000271	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—thyroid cancer	2.07e-05	0.000262	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—thyroid cancer	2.05e-05	0.00026	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—thyroid cancer	2.02e-05	0.000256	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—thyroid cancer	1.86e-05	0.000236	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRAS—thyroid cancer	1.84e-05	0.000233	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—thyroid cancer	1.83e-05	0.000232	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—thyroid cancer	1.75e-05	0.000221	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TPR—thyroid cancer	1.74e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.71e-05	0.000216	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—thyroid cancer	1.69e-05	0.000214	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—thyroid cancer	1.65e-05	0.000209	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—thyroid cancer	1.61e-05	0.000204	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—thyroid cancer	1.59e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRAS—thyroid cancer	1.51e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—thyroid cancer	1.48e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—thyroid cancer	1.41e-05	0.000179	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—thyroid cancer	1.41e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—thyroid cancer	1.35e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.3e-05	0.000165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—thyroid cancer	1.3e-05	0.000164	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—thyroid cancer	1.19e-05	0.000151	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.17e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—thyroid cancer	1.16e-05	0.000147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—thyroid cancer	1.15e-05	0.000146	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—thyroid cancer	1.1e-05	0.00014	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—RXRA—thyroid cancer	1.09e-05	0.000138	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—thyroid cancer	1.06e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—thyroid cancer	1.02e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—thyroid cancer	9.73e-06	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—thyroid cancer	8.11e-06	0.000103	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—thyroid cancer	6.89e-06	8.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—thyroid cancer	5.86e-06	7.42e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.42e-06	6.87e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—thyroid cancer	4.73e-06	5.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—thyroid cancer	2.72e-06	3.45e-05	CbGpPWpGaD
